A Real-Life One-Year Non-Interventional Study Assessing Safety, Tolerability, and Treatment Outcome of the SQ HDM SLIT-Tablet (Acarizax(®)) in House Dust Mite Allergic Rhinitis With or Without Asthma

INTRODUCTION: The aim of this study was to investigate the safety profile, tolerability, and outcome of the SQ(®) house dust mite (HDM) sublingual immunotherapy (SLIT)-tablet after 1 year of treatment in clinical practice among adults with HDM-related allergic rhinitis (AR) ± allergic asthma (AA). M...

Descripción completa

Detalles Bibliográficos
Autores principales: Sidenius, Kirsten, Arvidsson, Peter, Indbryn, Roger, Emanuelsson, Cecilia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137770/
https://www.ncbi.nlm.nih.gov/pubmed/33772732
http://dx.doi.org/10.1007/s41030-021-00150-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137770/
https://www.ncbi.nlm.nih.gov/pubmed/33772732
http://dx.doi.org/10.1007/s41030-021-00150-z

Ejemplares similares